Abstract:Background: Needle-free vaccine delivery systems have many potential advantages including increased vaccine compliance and decreased risk of needlestick injuries and syringe reuse. The Med-Jet® H4 is a gas-powered, auto-disabling disposable syringe jet injector. The Med-Jet family of products are currently being used in dermatology, podiatry, pain management and veterinary practices. The objectives of this study were to assess patient attitudes, time-efficiency, safety and immunogenicity of the seasonal influenza vaccine delivered by Med-Jet compared to the traditional needle-and-syringe. Methods: A total of 80 patients were randomized 2:1:1 to receive a commercial trivalent vaccine by Med-Jet or needle injection from a single-dose or multi-dose vial. Patient attitudes were assessed pre-randomization and post-immunization. Safety data were collected for 21 days post-immunization. Efficiency of vaccine administration was measured through a time-and-motion study. Humoral and cellular responses were assessed on Days 0 and 21. Results: Overall, the participants readily accepted Med-Jet vaccination despite greater frequency of transient local reactions (eg: redness, swelling) immediately following immunization. Vaccine administration took slightly longer with the Med-Jet, but this difference decreased over time. Geometric mean hemagglutination inhibition titers, seroconversion and seroprotection rates in the Med-Jet and needle groups were equivalent for all influenza strains in the vaccine. Microneutralization responses were also essentially identical. There were no significant differences between the groups in the frequency of functional CD4 + T cells, memory subset distribution or poly-functionality. Conclusions: These data suggest that the Med-Jet is an acceptable means of delivering seasonal influenza vaccine. The system was attractive to subjects, rapidly learned by skilled vaccine nurses and elicited both humoral and cellular responses that were indistinguishable from those elicited with needle injection. While other studies have assessed the humoral response to jet injection of influenza vaccine, to our knowledge, this study is the first to assess the cellular aspect of this response. (ClinTrials.gov-NCT03150537).

Preventing Contamination Between Injections with Multiple-Use Nozzle Needle-Free Injectors: A Safety Trial

Dissolving Microneedle Arrays As a Hepatitis B Vaccine Delivery System Adjuvanted by APC-Targeted Poly (Lactic-Co-glycolic Acid) (PLGA) Nanoparticles

Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques

Characterization of Hepatitis B Surface Antigen Loaded Polylactic Acid-Based Microneedle and Its Dermal Safety Profile

A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery

Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection

A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant

Enfuvirtide plasma levels and injection site reactions using a needle-free gas-powered injection system (Biojector)

Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.

Clinical acceptability and ease of use of a safety IV catheter system

Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis

Injection site microflora in persons with diabetes: why needle reuse is not associated with increased infections?

Needle-free injection of insulin powder: delivery efficiency and skin irritation assessment.

Enhanced immunity in intradermal vaccination by novel hollow microneedles

Clinical Application of a Safe Blood Sampling Device with an Indwelling Needle

Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns

Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial

Ensuring injection safety during measles immunization campaigns: more than auto-disable syringes and safety boxes

Preventing Needlestick Injuries among Healthcare Workers: A WHO-ICN Collaboration

Injectability of high concentrated suspensions using model microparticles

Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination